Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: Oct 21, 2011 (rev. 1)

Premium

NSF Bioinformatics Grants Awarded Sept. 22 — Oct. 19, 2011

Sample Classification and Biomarker Discovery by Comprehensive Metabolomic Analysis
Start Date: Oct. 1, 2011
Expires: Sept. 30, 2013
Awarded Amount to Date: $499,976
Principal Investigator: Stephen Reichenbach
Sponsor: GC Image

Supports development of a system for automated classification of biological samples and discovery of biomarkers. According to the investigator, the system will be designed to perform comprehensive pattern analysis of biochemical separations generated by comprehensive two-dimensional chromatography with high-resolution mass spectrometry. It will incorporate methods for multidimensional peak detection, peak pattern matching across large sample sets, data alignment, comprehensive feature matching, and multi-sample analyses with large sample sets.


Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.